Signal transduction mediated by endostatin directly modulates cellular function of lung cancer cells in vitro

被引:13
作者
Cui, Ri [1 ]
Ohashi, Rina
Takahashi, Fumiyuki
Yoshioka, Masakata
Tominaga, Shigeru
Sasaki, Shinichi
Gu, Tao
Takagi, Yumiko
Takahashi, Kazuhisa
机构
[1] Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Res Inst Dis Old Ages, Tokyo 1138421, Japan
关键词
D O I
10.1111/j.1349-7006.2007.00459.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endostatin (ED) is a carboxyl-terminal fragment of collagen XVIII with strong antiangiogenic activity. ED has been considered as a highly specific inhibitor of endothelial cell proliferation and migration through interaction with its receptor on the surface of endothelial cells. Recently, direct antitumor effects of ED in colon cancer cells and head and neck squamous cell carcinoma cells has been reported. However, its effect on lung cancer cells has not been clarified. The purpose of the present study was to determine the effect of ED on in vitro lung cancer cell function and to identify its receptor on lung cancer cells. We revealed that alpha 5 integrin is capable of being a functional ED receptor among several integrins that are expressed on murine lung cancer (Lewis lung cancer [LLC]) cells. We further demonstrated that the ED-integrin interaction modulates various in vitro biological functions of LLC cells as we revealed that immobilized ED helps in LLC cell adhesion and migration in an integrin-dependent manner. Furthermore, ED inhibited LLC cell proliferation and induced apoptosis. Interestingly, ED did not demonstrate any antiproliferative activity against the other murine lung cancer cell line, KLN205, that lacks alpha 5 integrin but binds to immobilized ED through the beta 1 integrin. In addition, the binding of ED to alpha 5 integrin on LLC cells induced phosphorylation of focal adhesion kinase. Taken together, these results suggest that the interaction between ED and alpha 5 integrin may play an important role in lung cancer cell function.
引用
收藏
页码:830 / 837
页数:8
相关论文
共 30 条
[1]   Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].
Bergers, G ;
Javaherian, K ;
Lo, KM ;
Folkman, J ;
Hanahan, D .
SCIENCE, 1999, 284 (5415) :808-812
[2]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[3]   Anti-angiogenic agents: clinical trial design and therapies in development [J].
Deplanque, G ;
Harris, AL .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) :1713-1724
[4]  
Dhanabal M, 1999, CANCER RES, V59, P189
[5]   Endostatin induces endothelial cell apoptosis [J].
Dhanabal, M ;
Ramchandran, R ;
Waterman, MJF ;
Lu, H ;
Knebelmann, B ;
Segal, M ;
Sukhatme, VP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) :11721-11726
[6]   Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis [J].
Dixelius, J ;
Larsson, H ;
Sasaki, T ;
Holmqvist, K ;
Lu, LG ;
Engström, Å ;
Timpl, R ;
Welsh, M ;
Claesson-Welsh, L .
BLOOD, 2000, 95 (11) :3403-3411
[7]   Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells [J].
Dkhissi, F ;
Lu, H ;
Soria, C ;
Opolon, P ;
Griscelli, F ;
Liu, HF ;
Khattar, P ;
Mishal, Z ;
Perricaudet, M ;
Li, H .
HUMAN GENE THERAPY, 2003, 14 (10) :997-1008
[8]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[9]   An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action [J].
Gradishar, WJ .
INVESTIGATIONAL NEW DRUGS, 1997, 15 (01) :49-59
[10]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364